Chardan Capital downgraded shares of GenSight Biologics (OTCMKTS:GSGTF – Get Rating) from a buy rating to a neutral rating in a research note issued to investors on Thursday morning, The Fly reports. GenSight Biologics Stock Down 1.6 % Shares of GSGTF stock opened at $3.10 on Thursday. GenSight Biologics has a 12-month low of $3.10 […]
GenSight Biologics (OTCMKTS:GSGTF – Get Rating) was downgraded by stock analysts at Chardan Capital from a “buy” rating to a “neutral” rating in a research note issued on Thursday, The Fly reports. GenSight Biologics Stock Performance GenSight Biologics stock remained flat at $3.10 during midday trading on Thursday. GenSight Biologics has a 1 year low […]
Using a new approach for studying live embryonic mouse brains at single-cell resolution, researchers have identified an active multi-layer circuit that forms in the cortex during an unexpectedly early stage of development. Perturbing the circuit genetically led to changes similar to those seen in the brains of people with autism. The findings are reported today in Cell by a team based at the Institute of Molecular and Clinical Ophthalmology Basel.